Related references
Note: Only part of the references are listed.Vergleich der Methoden zur Uberwachung der Trilostanbehandlung von Hunden mit Hyperkortisolismus
Eva Rompa
KLEINTIERPRAXIS (2023)
Metabolomic serum abnormalities in dogs with hepatopathies
Carolin A. Imbery et al.
SCIENTIFIC REPORTS (2022)
Association between ACTH stimulation test results and clinical signs in dogs with hyperadrenocorticism treated with trilostane
A. Wehner et al.
VETERINARY JOURNAL (2021)
Endogenous cortisol excess confers a unique lipid signature and metabolic network
Arturo Vega-Beyhart et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2021)
Machine-learning based prediction of Cushing's syndrome in dogs attending UK primary-care veterinary practice
Imogen Schofield et al.
SCIENTIFIC REPORTS (2021)
Identification of human glucocorticoid response markers using integrated multi-omic analysis from a randomized crossover trial
Dimitrios Chantzichristos et al.
ELIFE (2021)
Metabolic profiling of serum from dogs with pituitary-dependent hyperadrenocorticism
Alberto Munoz-Prieto et al.
RESEARCH IN VETERINARY SCIENCE (2021)
A novel canine nuclear magnetic resonance spectroscopy-based metabolomics platform: Validation and sample handling
Claudia Ottka et al.
VETERINARY CLINICAL PATHOLOGY (2021)
Comparison of methods to monitor dogs with hypercortisolism treated with trilostane
Stefania Golinelli et al.
JOURNAL OF VETERINARY INTERNAL MEDICINE (2021)
Machine learning algorithm as a diagnostic tool for hypoadrenocorticism in dogs
K. L. Reagan et al.
DOMESTIC ANIMAL ENDOCRINOLOGY (2020)
Evaluation of dose-response effects of short-term oral prednisone administration on clinicopathologic and hemodynamic variables in healthy dogs
Rebecca L. Tinklenberg et al.
AMERICAN JOURNAL OF VETERINARY RESEARCH (2020)
Effect of congenital adrenal hyperplasia treated by glucocorticoids on plasma metabolome: a machine-learning-based analysis
Lee S. Nguyen et al.
SCIENTIFIC REPORTS (2020)
Lipoprotein particles in patients with pediatric Cushing disease and possible cardiovascular risks
Angeliki Makri et al.
PEDIATRIC RESEARCH (2019)
Diagnosis of spontaneous hyperadrenocorticism in dogs. Part 1: Pathophysiology, aetiology, clinical and clinicopathological features
Michael Bennaim et al.
VETERINARY JOURNAL (2019)
Changes in the Canine Plasma Lipidome after Short- and Long-Term Excess Glucocorticoid Exposure
Nadja S. Sieber-Ruckstuhl et al.
SCIENTIFIC REPORTS (2019)
Prednisolone dosages in Addisonian dogs after integration of ACTH measurement into treatment surveillance
Florian K. Zeugswetter et al.
TIERAERZTLICHE PRAXIS AUSGABE KLEINTIERE HEIMTIERE (2018)
Cortisol-related metabolic alterations assessed by mass spectrometry assay in patients with Cushing's syndrome
Guido Di Dalmazi et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2017)
Plasma metabolomic profile varies with glucocorticoid dose in patients with congenital adrenal hyperplasia
Mohammad A. Alwashih et al.
SCIENTIFIC REPORTS (2017)
Lack of association between clinical signs and laboratory parameters in dogs with hyperadrenocorticism before and during trilostane treatment
F. S. Boretti et al.
SCHWEIZER ARCHIV FUR TIERHEILKUNDE (2016)
GlycA: A Composite Nuclear Magnetic Resonance Biomarker of Systemic Inflammation
James D. Otvos et al.
CLINICAL CHEMISTRY (2015)
Adrenal insufficiency
Evangelia Charmandari et al.
LANCET (2014)
Assessing the metabolic effects of prednisolone in healthy volunteers using urine metabolic profiling
Sandrine Ellero-Simatos et al.
GENOME MEDICINE (2012)
Monitoring the response of canine hyperadrenocorticism to trilostane treatment by assessment of acute phase protein concentrations
A. Arteaga et al.
JOURNAL OF SMALL ANIMAL PRACTICE (2010)
Pathophysiology of Dyslipidemia in Cushing's Syndrome
Giorgio Arnaldi et al.
NEUROENDOCRINOLOGY (2010)
High-throughput serum NMR metabonomics for cost-effective holistic studies on systemic metabolism
Pasi Soininen et al.
ANALYST (2009)
Chromatographic analysis of lipid fractions in healthy dogs and dogs with obesity or hyperadrenocorticism
Marcia Marques Jerico et al.
JOURNAL OF VETERINARY DIAGNOSTIC INVESTIGATION (2009)
Serum acute phase protein concentrations in dogs with hyperadrenocorticism with and without concurrent inflammatory conditions
Marco Caldin et al.
VETERINARY CLINICAL PATHOLOGY (2009)
Glucocorticoids and fatty acid metabolism in humans: fuelling fat redistribution in the metabolic syndrome
David P. Macfarlane et al.
JOURNAL OF ENDOCRINOLOGY (2008)
Comparison of classic hypoadrenocorticism with glucocorticoid-deficient hypoadrenocorticism in dogs: 46 cases (1985-2005)
Ann L. Thompson et al.
JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION (2007)
Diagnosis of hyperadrenocorticism in dogs
Mark E. Peterson
CLINICAL TECHNIQUES IN SMALL ANIMAL PRACTICE (2007)
Hypoadrenocorticism in small animals
Deborah S. Greco
CLINICAL TECHNIQUES IN SMALL ANIMAL PRACTICE (2007)
Metabolomics: Current technologies and future trends
Katherine Hollywood et al.
PROTEOMICS (2006)
Haptoglobin concentrations in dogs undergoing trilostane treatment for hyperadrenocorticism
YL McGrotty et al.
VETERINARY CLINICAL PATHOLOGY (2005)
High cardiovascular risk in patients with Cushing's syndrome according to 1999 WHO/ISH guidelines
T Mancini et al.
CLINICAL ENDOCRINOLOGY (2004)
Diagnosis and complications of Cushing's syndrome: A consensus statement
G Arnaldi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Haptoglobin concentrations in a canine hospital population
YL McGrotty et al.
VETERINARY RECORD (2003)
Evaluation of circulating levels and renal clearance of natural amino acids in patients with Cushing's disease
A Faggiano et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2002)
Diagnosis of canine hyperadrenocorticism
EN Behrend et al.
VETERINARY CLINICS OF NORTH AMERICA-SMALL ANIMAL PRACTICE (2001)
Lipid and fatty acid composition of canine lipoproteins
EN Maldonado et al.
COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY B-BIOCHEMISTRY & MOLECULAR BIOLOGY (2001)
Share Paper
